medline.ch Gastroenterologie Pankreas Neoplasie

	Early postoperative serum IL-6 may contribute to risk stratification for pancreas-specific complications after pancreatic resection. Langenbecks Arch Surg Schulte-Hürmann H, Koca F, Wicke J, Mazzella E, Benkö T, Wiegering A, Petrova E. PMID: 42742801 [PubMed - indexed for MEDLINE]
	Associations of oral microbiome diversity with prevalent cancer: a population-based cross-sectional study. Arch Microbiol An Y, Pang C, Wu Z, Chu Y, Wan W, Gao S, Pu N. PMID: 42742726 [PubMed - indexed for MEDLINE]
	Surgical outcomes after robot-assisted versus laparoscopic pancreatoduodenectomy: multicentre propensity-matched comparison from the Italian Group of Minimally Invasive Pancreatic Surgery. BJS Open Quero G, Menghi R, Napoli N, Ripolli A, Ferrari G, Mazzola M, Bannone E, Butturini G, Viola MG, Garatti M, Tebala G, Di Benedetto F, Moraldi L, Molino C, Alfieri S, Bracale U, Troisi R, Dalla Valle R, Vivarelli M, Jovine E, Memeo R, Garulli G, Ottaviani L, Berti S, Coratti A, Ercolani G, Salvia R, Morelli L, Casadei R, Coppola R, Brolese A, Tondolo V, Zerbi A, Boggi U, IGOMIPS Registry Study Group. PMID: 42742083 [PubMed - indexed for MEDLINE]
	Efficacy of UFT combined with radiotherapy in advanced pancreatic cancer: a systematic review and meta-analysis. Front Oncol Shang X, Wang X, Cen J, Yang F, Li J, Zhao H. PMID: 42741119 [PubMed]
	The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Clin Public Health Guidel Leeuwenburgh LC, Holze M, Akhoundzadeh D, Alsourani A, Jimenez RA, Andel PCM, van Houweninge CB, Balduzzi A, Bruna CL, Casciani F, Cattelani A, van Diepen AE, Driessens H, Droogh DHM, Fritzsche JA, van Gansewinkel E, Genova L, Gehrels AM, Dueñas GG, Guastella R, Hoeijmakers LSM, Hoogteijling TJ, Javed AA, Aktas BK, Kinny-Köster B, Lamoré A, Seng Liem K, Lionetto G, Faro LL, Lutter L, Mastronardi M, Maurer CH, Montorsi R, Musa J, Rompen IF, Scheepens JCM, Sochorová D, Stoop TF, Tezcan N, Uijterwijk BA, Vella R, Vernuccio F, Voermans RP, Hilal MA, Adsay V, Algül H, Ambrosini V, Archibugi L, Backman E, Barbu ST, Boggi U, Borge-Andersen C, Burgdorf SK, Clarkson A, van Cutsem E, Cuyle PJ, Daamen LA, Rosa P, den Dulk M, de Los Rios CD, Drury A, Esposito I, Everett SM, Sarasqueta AF, Frigerio I, Koerkamp BG, Hackert T, Huguet F, Kartalis N, Letsch A, Langenberg P, Levett D, Liposits G, Malats N, van Malenstein H, Malleo G, Maravic Z, Marchegiani G, Martins A, Meijerink MR, Michalski CW, Mieog JSD, Moka E, Mukherjee S, Nanni C, Orsi F, Papamichael D, Partelli S, Payne C, Pergolini I, Radenkovic D, Roberts KJ, Salvia R, Sauvanet A, Scorsetti M, Seebo M, Seufferlein T, Stättner S, Vanbiervliet G, Verbeke CS, Volk T, Werner J, Wilmink JW, Zins M, Conroy T, Pfeiffer P, Ducreux M, Ali M, Langendam M, Vali Y, Rangelova EB, Besselink MG, Multi. PMID: 42740762 [PubMed]
	Biglycan Secreted by Tumor Stromal Cells Is a Predictive Marker for the Early Recurrence of Pancreatic Cancer. Pathol Int Tanaka H, Maishi N, Matsuda A, Morimoto H, Fujii M, Tsumita T, Mitsuhashi T, Matsuno Y, Hida Y, Nakamura T, Hirano S, Hida K. PMID: 42740565 [PubMed - indexed for MEDLINE]
	Recorded Early Imaging Responses After Transarterial Chemoembolization Plus Lenvatinib Versus Transarterial Chemoembolization Without Documented Lenvatinib for Unresectable Hepatocellular Carcinoma: A Vietnamese Cohort Study. J Clin Med Minh VL, Hung NV, Anh PT, Anh PT, Thong PM. PMID: 42739846 [PubMed]
	Mitoxyperilysis Drives Immunosuppressive Tumor Microenvironment Remodeling and Hepatocellular Carcinoma Progression via ANXA1-Mediated Macrophage M2 Polarization. Cancers (Basel) Qin M, He W, Wu G. PMID: 42738308 [PubMed]
	Beyond Canonical Neoantigens: Emerging Technologies for Identification of Noncanonical Antigens and Implications for Personalized Cancer Vaccines. Cancers (Basel) Yang Y, Kane T, Abdelzaher AT, Goedegebuure SP, Gillanders WE. PMID: 42738301 [PubMed]
	Targeting Reactive Species Stress and Nutrient Sensing to Enhance NK-Cell Function: Mechanistic Strategies for Overcoming Pancreatic Cancer Progression and Resistance Through Supplement Therapy. Int J Mol Sci Fanijavadi S, Jensen LH. PMID: 42737789 [PubMed - indexed for MEDLINE]
	Metabolic Dysfunction and Related Dietary Exposures in Relation to Pancreatic Cancer Risk: A Review of the Evidence. Int J Mol Sci Yang J, Huang Y, Lophatananon A, Muir KR. PMID: 42737603 [PubMed - indexed for MEDLINE]
	Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy. Int J Mol Sci Yeganeh HT, Sellat M, Anis Z, Chiri R, Patnaik R, Gambhir S, Banerjee Y. PMID: 42737430 [PubMed - indexed for MEDLINE]
	The use of blood test trends in cancer detection: a scoping review. Diagn Progn Res Zhu S, Friedemann Smith C, Collins KK, Ziyenge SE, Murphy J, de Vere Hunt I, Brubert Z, Roberts N, Morris EJA, Hobbs R, Nicholson BD, Virdee PS. PMID: 42736584 [PubMed]
	Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75â€‰Years and Older With Unresectable Pancreatic Cancer. Cancer Rep (Hoboken) Ikezawa K, Imai T, Takada R, Yamai T, Fukutake N, Urabe M, Kai Y, Mukai K, Nakabori T, Ohkawa K. PMID: 42735912 [PubMed - indexed for MEDLINE]
	Pancreatic ductal adenocarcinoma: The Vision of Heracles. Cancer Cell Mota Reyes C, Goetz MR, Algül H, Dogruoez A, Falcomatà C, Gaida MM, Görgülü K, Gültekin Y, Gürcinar IH, Hasselluhn MC, Istvanffy R, Kalluri R, Kalluri VS, Kiemen A, Kim P, Lee SW, Lesina M, Yu P, Maitra A, Müller CM, Müller S, Nam D, Olive KP, Pasca Di Magliano M, Rad R, Saur D, Vander Heiden MG, Vormehr M, Wood LD, Yöndem E, Zschäpitz D, Karakas D, Friess H, Ceyhan GO, European Pancreatic Club (EPC) Pancreatic Cancer Think Tank Group, Demir IE. PMID: 42735679 [PubMed - indexed for MEDLINE]
	Neural regulation of cancer: from microenvironmental hijacking to systemic circuit co-option. Cell Oncol (Dordr) Gu Z, Ma H, Jiang GQ, Wei J. PMID: 42734679 [PubMed - indexed for MEDLINE]
	Clinicopathological differences and risk factors of early- versus late-onset pancreatic cancer: A systematic review and meta-analysis. iScience Alzoubi M, Al Jibarat R, Saleh AO, Eisa R, Al-Sha'ar HM, Alfreijat TM, Habboub J, Rashed R, Hanoun R, Alkhateeb R, Hamady Z. PMID: 42733648 [PubMed]
	Experiences of Families Supporting Patients With Refractory Cancer: An Interpretive Descriptive Study. Glob Qual Nurs Res Morishita J, Tamura R, Shigeta R, Yatomi Y. PMID: 42733430 [PubMed]
	Converging endoscopic techniques and artificial intelligence for diagnosis and risk stratification of pancreatic cystic neoplasms. Chin Med J (Engl) Guo Y, Li X, Xie X, Liao X, Wang C, Wang R. PMID: 42733303 [PubMed - as supplied by publisher]
	The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer. Ann Surg Oncol Schaefer ML, Tsai S, Blair AB. PMID: 42732021 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 61523

Seite 1 von 3077

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung